tiprankstipranks
Trending News
More News >
Innate Pharma S.A. (FR:IPH)
:IPH
France Market
Advertisement

Innate Pharma SA (IPH) Technical Analysis

Compare
6 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Innate Pharma S.A.’s (IPH) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Innate Pharma S.A. is a Buy.
Innate Pharma S.A.’s (IPH) 20-Day exponential moving average is 1.88, while Innate Pharma S.A.’s (IPH) share price is €1.86, making it a Sell.
Innate Pharma S.A.’s (IPH) 50-Day exponential moving average is 1.82, while Innate Pharma S.A.’s (IPH) share price is €1.86, making it a Buy.

Innate Pharma SA (IPH) Pivot Points

Aug 29, 2025, 05:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.74
1.78
1.81
1.85
1.88
1.92
1.96
Fibonacci
1.78
1.81
1.82
1.85
1.88
1.90
1.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Innate Pharma SA (IPH) Moving Averages

Aug 29, 2025, 05:15 PM
Period
Simple
Exponential
MA5
1.90Sell
1.89Sell
MA10
1.94Sell
1.91Sell
MA20
1.90Sell
1.88Sell
MA50
1.73Buy
1.82Buy
MA100
1.79Buy
1.81Buy
MA200
1.81Buy
1.81Buy
Innate Pharma S.A.’s (IPH) 10-Day exponential moving average is 1.91, while Innate Pharma S.A.’s (IPH) share price is €1.86, making it a Sell.
Innate Pharma S.A.’s (IPH) 100-Day exponential moving average is 1.81, while Innate Pharma S.A.’s (IPH) share price is €1.86, making it a Buy.
Innate Pharma S.A.’s (IPH) stock price is €1.86 and Innate Pharma S.A.’s (IPH) 50-day simple moving average is 1.73, creating a Buy signal.
Innate Pharma S.A.’s (IPH) stock price is €1.86 and Innate Pharma S.A.’s (IPH) 100-day simple moving average is 1.79, creating a Buy signal.
Innate Pharma S.A.’s (IPH) stock price is €1.86 and Innate Pharma S.A.’s (IPH) 200-day simple moving average is 1.81, creating a Buy signal.

Innate Pharma SA (IPH) Technical Indicators

Aug 29, 2025, 05:15 PM
Name
Value
Implied Action
RSI (14)
49.28
Neutral
STOCH (9,6)
10.83
Buy
STOCHRSI (14)
19.26
Buy
MACD (12,26)
0.04
Buy
ADX (14)
34.71
Neutral
Williams %R
-79.47
Buy
CCI (14)
-50.07
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
32.47
Neutral
ROC
1.20
Buy
Innate Pharma S.A.’s (IPH) Relative Strength Index (RSI) is 49.28, creating a Neutral signal.
Innate Pharma S.A.’s (IPH) Trend Strength Indicator (ADX) is 34.71, creating a Neutral signal.
Innate Pharma S.A.’s (IPH) Commodity Channel Index (CCI) is -50.07, creating a Neutral signal.
Innate Pharma S.A.’s (IPH) Price Rate of Change (ROC) is 1.20, creating a Buy signal.

FAQ

Is IPH a Buy, Hold, or Sell?
Based on IPH’s technical indicators, IPH is a Buy.
    What is IPH’s RSI (14)?
    IPH’s RSI (14) is 49.28, which suggests IPH is a Neutral.
      What is IPH’s MACD?
      IPH’s MACD is 0.04, which suggests IPH is a Buy.
        What is IPH’s 5-day moving average?
        IPH’s 5-day moving average is 1.90, which suggests IPH is a Sell.
          What is IPH’s 20-day moving average?
          IPH 20-day moving average is 1.90, which suggests IPH is a Sell.
            What is IPH’s 50-day moving average?
            IPH’s 50-day moving average is 1.73, which suggests IPH is a Buy.
              What is IPH’s 200-day moving average?
              IPH’s 200-day moving average is 1.81, which suggests IPH is a Buy.
                What is IPH’s Williams % R (14)?
                IPH’s Williams % R (14) is -79.47, which suggests IPH is a Buy.
                  What is IPH’s CCI (14)?
                  IPH’s CCI (14) is -50.07, which suggests IPH is a Neutral.
                    What is the share price of Innate Pharma S.A.?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis